1. Home
  2. MLAB vs MYI Comparison

MLAB vs MYI Comparison

Compare MLAB & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • MYI
  • Stock Information
  • Founded
  • MLAB 1982
  • MYI 1992
  • Country
  • MLAB United States
  • MYI United States
  • Employees
  • MLAB N/A
  • MYI N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • MYI Investment Bankers/Brokers/Service
  • Sector
  • MLAB Industrials
  • MYI Finance
  • Exchange
  • MLAB Nasdaq
  • MYI Nasdaq
  • Market Cap
  • MLAB 680.0M
  • MYI 723.2M
  • IPO Year
  • MLAB N/A
  • MYI N/A
  • Fundamental
  • Price
  • MLAB $112.01
  • MYI $10.43
  • Analyst Decision
  • MLAB Hold
  • MYI
  • Analyst Count
  • MLAB 2
  • MYI 0
  • Target Price
  • MLAB $140.00
  • MYI N/A
  • AVG Volume (30 Days)
  • MLAB 58.3K
  • MYI 256.7K
  • Earning Date
  • MLAB 05-30-2025
  • MYI 01-01-0001
  • Dividend Yield
  • MLAB 0.57%
  • MYI 4.81%
  • EPS Growth
  • MLAB N/A
  • MYI N/A
  • EPS
  • MLAB N/A
  • MYI N/A
  • Revenue
  • MLAB $237,747,000.00
  • MYI N/A
  • Revenue This Year
  • MLAB $13.48
  • MYI N/A
  • Revenue Next Year
  • MLAB $4.74
  • MYI N/A
  • P/E Ratio
  • MLAB N/A
  • MYI N/A
  • Revenue Growth
  • MLAB 11.68
  • MYI N/A
  • 52 Week Low
  • MLAB $83.68
  • MYI $9.32
  • 52 Week High
  • MLAB $155.12
  • MYI $11.70
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 42.12
  • MYI 38.83
  • Support Level
  • MLAB $109.95
  • MYI $10.16
  • Resistance Level
  • MLAB $117.85
  • MYI $10.54
  • Average True Range (ATR)
  • MLAB 8.18
  • MYI 0.19
  • MACD
  • MLAB 0.63
  • MYI -0.03
  • Stochastic Oscillator
  • MLAB 59.94
  • MYI 42.06

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About MYI Blackrock MuniYield Quality Fund III Inc

BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.

Share on Social Networks: